Loading...
Loading...
Investing is risky. You might not know what you'll earn, it could be hard to sell, you might own less, unexpected things can happen, and you could lose all your money.
Crigen Accor Life Science
Crigen Accor Life Science is a Malaysian-based private label health and beauty one stop manufacturer. Its mission is to change the world 1 product at a time by delivering high quality, eco-friendly, safe, and affordable health and beauty private label products to its partners and customers.
Crigen Accor Life Science is a Malaysian-based private label health and beauty one stop manufacturer. Its mission is to change the world 1 product at a time by delivering high quality, eco-friendly, safe, and affordable health and beauty private label products to its partners and customers.
MIN INVESTMENT
RM 5,014
MIN TARGET
RM 500,000
MAX TARGET
RM 1,500,000
DIVIDEND
Ordinary Shares
SHARE TYPE
Ordinary Shares
SHARE PRICE
RM 2.03
VALUATION
RM 20,276,342
Our mission in Crigen Accor Life Science is to change the world 1 product at a time by delivering high quality, eco-friendly, safe and affordable health and beauty private label products to our partners and customers. We are a Malaysian-based private label health and beauty products manufacturer and also an original equipment and contract manufacturing company.
We believe that by unlocking the power of nature through scientific precision and innovation, we are able to design highly responsible, economical and consumer-friendly products that are highly effective for our customers.
Reliability Issues
High MOQ, Production Cost & Initial Startup Cost
Lack of Support in Product Sales & Marketing
Crigen Accor has already formulated and designed 5 products to start with and we are now ready to move into manufacturing and production. We are looking to set up a manufacturing plant in Semenyih, Selangor. We have also gained major traction by securing an exclusive contract from Crigen Resources Sdn Bhd worth approximately RM 1.5 million. With this round of funding, our objective is to ramp up our manufacturing plant and expand our sales and marketing efforts.
20% for Sales & Marketing, 50% for Production & Manufacturing Facilities, 20% for Inventory & Logistics, 10% for Research & Development.
Managing Director
Managing Director
Management Executive
Ordinary Shares
The Issuer intends to raise up to RM 1,500,000 in this fundraising exercise.
RM 500,000
RM 1,500,000
RM 2.03 per share
246,306 shares
738,917 shares
RM 5,014
Retail, Angel, Sophisticated, and/or Institutional Investors, subject to the applicable investment limits prescribed under the Securities Commission’s Guidelines on Recognised Markets.
14 working days after the end of the Fundraising Period.
An Investment Agreement for the subscription of the Shares (subject to review if required or necessary).
The information, calculations and remarks expressed on this term sheet or on any other part of the platform are based on information provided, disclosed and presented by the Issuer, Crigen Accor Life Science Sdn Bhd to Ata Plus Sdn Bhd, either in part or in whole. Ata Plus disclaims responsibility for the accuracy, completeness and/or validity of these information, and hence will not be held liable for any inaccurate, inappropriate or incomplete information presented on this term sheet or on any other part of the platform subject to the following :
The financial information listed on the Deal page is provided by the Issuer; which includes the financial forecasts and projections, the capitalisation table, the term sheet, and management accounts.
The financial forecasts and projections have been prepared by the Issuer based on assumptions that have not been reviewed and certified by an independent certified accountant for its reasonableness.
The Issuer agrees that; all information concerning the product, business and the assets of the Issuer that have been furnished to Ata Plus Sdn Bhd for the purpose of the equity crowdfunding campaign is true, complete, and accurate in all material respects and is not misleading or deceptive whether by inclusion or omission.
Should the Investor require more information, they can do so by contacting Crigen Accor Life Science Sdn Bhd directly at ice.alan@gmail.com.
(i) No shares will be alotted or issued based on this document after six months from the closing of the offer period
(ii) This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007
(iii) This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.
Sign in to access company documents and detailed information
Don't have an account? Register here
View our detailed presentation slides
RM 1,500,000
of RM 500,000
Min Target
RM 500,000
Max Target
RM 1,500,000
Investing in equity crowdfunding involves certain risks that include uncertainty of returns, lack of liquidity, dilution, material events and lack of control. Investments should be done as part of a diversified portfolio. ATA PLUS offers investment opportunities to investors who understands these risks in making their own investment decisions.
PLEASE READ THE FULL RISK WARNING BEFORE DECIDING TO INVEST.
This page is approved as a financial promotion by ATA PLUS Sdn. Bhd., which is authorized and regulated by the Security Commission of Malaysia. Deals that are up for investment are only offered to members of ata-plus.com on the basis of information provided by the companies concerned. ATA PLUS takes no responsibility for this information or for any recommendations or opinions made by the companies. For further information on this, please read our Term of Use.
RM 1,500,000
of RM 500,000
Min Target
RM 500,000
Max Target
RM 1,500,000
Min Investment
RM 5,014